文献库搜索 | GeneLibs

Andres(S),Brown(DN),Da Cruz Paula(A),Aghaj... Gynecol Oncol 2025-10-00

...PIK3CA (60 %), FBXW7 (40 %), PPP2R1A (30 %) mutations, CCNE1 (50 %) and AKT2 amplification (30 %). All serous ECs were h...

Wedam(S),Narayan(P),Gittleman(H),Cheng(J),... J Clin Oncol 2025-10-00

...PIK3CA-mutated, hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative, locally advanced or...

Martinez-Enriquez(LC),Bernal-Estévez(DA),A... Front Oncol None

...PIK3CA (p.Glu542Lys), all supported by OncoKB level-1 evidence. This case highlights the potential of integrating precis...

Koyanagi(A),Kakumoto(A),Kuroda(H),Baba(S),... Case Rep Oncol 2025-00-00

...PIK3CA, ARID1A, NF2, SETBP1, and EP300. Of these, tumor heterogeneity and genetic alterations, including mutations in AR...

Loizidis(S),Stanciu(MA),Ignatiadis(M) Curr Opin Oncol 2025-09-01

...PIK3CA, ESR1, etc.). Various ctDNA assays used in randomized trials have been approved by regulatory authorities as comp...

Vera-Amaya(FD),Gomez-Restrepo(JI),Fontecha... R I Med J (2013) 2025-09-02

...PIK3CA gene, characterized classically by a triad of capillary malformations, venous malformations, and soft tissue and ...

Mi(X),Ye(ZL),Zhang(XJ),Chen(XC),Dai(XM) Biol Sex Differ 2025-09-02

...Pik3ca), and some regulatory genes (Adm, Zfpm2 and Nr3c1). A similar outcome was found in the 10-month mice when compare...

Harary(PM),Hori(YS),Kattaa(AH),Lam(FC),Abu... J Clin Neurosci 2025-11-00

...PIK3CA (p.E545K) or BRCA2 (p.K3326*). Our case series indicates that SRS may be an effective management option for erCCC...

Yamane(N),Matoba(Y),Yamazaki(T),Uyama(T),E... Case Rep Oncol 2025-00-00

...PIK3CA. BRCA1, a major causative gene of hereditary breast and ovarian cancer, may also contribute to the risk of USC. W...

Sun(C),Li(Q),Huang(Y),Xia(Y),Li(M),Zhu(X),... Front Oncol None

...PIK3CA), and mammalian target of rapamycin (mTOR), which are frequently linked with targeted therapy for endometrial can...